“…• protein kinase C (PKC) inhibition or calmodulin pathways that may account for tamoxifen inhibition of cell growth (Jiang 1995); • inhibition of some intracellular biochemical reaction which might be independent of epidermal growth factor receptor interactions (Francavilla 1989).…”
Section: How the Intervention Might Workmentioning
To assess the benefits and harms of tamoxifen in people with hepatocellular carcinoma, irrespective of sex, administered dose, type of formulation, and duration of treatment.
“…• protein kinase C (PKC) inhibition or calmodulin pathways that may account for tamoxifen inhibition of cell growth (Jiang 1995); • inhibition of some intracellular biochemical reaction which might be independent of epidermal growth factor receptor interactions (Francavilla 1989).…”
Section: How the Intervention Might Workmentioning
To assess the benefits and harms of tamoxifen in people with hepatocellular carcinoma, irrespective of sex, administered dose, type of formulation, and duration of treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.